Product Information
PHENTERMINE 37.5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0708 per EA under NDC 43547040410. Its NADAC has been published 446 times since Dec 13, 2017.
Strength
37.5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547040410
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040377On Market Since
1/4/2002
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG TABLET has been published 446 times since Dec 13, 2017, and over the history we have for it it has declined 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0708 per EA |
|---|---|
| All-time high | $0.1144 (Mar 14, 2018) |
| All-time low | $0.0494 (Nov 20, 2024) |
| 52-week high | $0.0777 |
| 52-week low | $0.0670 |
| Median price | $0.0829 |
| Average price | $0.0827 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 446 |
| Tracking since | Dec 13, 2017 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0708 per EA (NDC 43547040410), effective Jun 24, 2026.
How has the price of PHENTERMINE 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG TABLET has declined 33.6%. It has been tracked across 446 weekly CMS publications since Dec 13, 2017.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG TABLET?
Since Dec 13, 2017, the NADAC for PHENTERMINE 37.5 MG TABLET has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.1144 (Mar 14, 2018), with a median of $0.0829 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 37.5 MG TABLET, is $0.0697 per EA — about 2% below PHENTERMINE 37.5 MG TABLET.
Who manufactures PHENTERMINE 37.5 MG TABLET?
PHENTERMINE 37.5 MG TABLET (NDC 43547040410) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification